skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The effect of food on gastrointestinal (GI) transit of sustained-release ibuprofen tablets as evaluated by gamma scintigraphy

Journal Article · · Pharmaceutical Research; (USA)
; ; ;  [1]
  1. Upjohn Company, Kalamazoo, MI (USA)

The GI transit of radiolabeled sustained-release ibuprofen 800-mg tablets in eight healthy, fed volunteers was monitored using external gamma scintigraphy. Ibuprofen serum concentrations were determined from blood samples drawn over 36 hr following dosing. Sustained-release ibuprofen tablets containing 0.18% of 170Er2O3 (greater than 96% 170Er) in the bulk formulation were manufactured under pilot-scale conditions and were radiolabeled utilizing a neutron activation procedure which converted stable 170Er to radioactive 171Er (t1/2 = 7.5 hr). At the time of dosing, each tablet contained 50 mu Ci of 171Er. Dosage form position were reported at various time intervals. In five subjects the sustained-release tablet remained in the stomach and eroded slowly over 7-12 hr, resulting in gradual increases in small bowel radioactivity. In the remaining three subjects, the intact tablet was ejected from the stomach and a gastric residence time of approximately 4 hr was measured. This is in marked contrast to a previous study conducted in fasted volunteers in which gastric retention time ranged from 10 to 60 min. Differences in GI transit between fed and fasted volunteers had little effect on ibuprofen bioavailability. AUC and Tmax were unaltered and Cmax was increased by 24%, which is in agreement with results from a previous, crossover-design food effect study.

OSTI ID:
6746788
Journal Information:
Pharmaceutical Research; (USA), Vol. 7:3; ISSN 0724-8741
Country of Publication:
United States
Language:
English

Similar Records

Correlation of ibuprofen bioavailability with gastrointestinal transit by scintigraphic monitoring of /sup 171/Er-labeled sustained-release tablets
Journal Article · Tue Dec 01 00:00:00 EST 1987 · Pharm. Res.; (United States) · OSTI ID:6746788

Gastrointestinal behavior of orally administered radiolabeled erythromycin pellets in man as determined by gamma scintigraphy
Journal Article · Sun Jul 01 00:00:00 EDT 1990 · Journal of Clinical Pharmacology; (USA) · OSTI ID:6746788

Plasma concentrations of remoxipride and the gastrointestinal transit of 111In-marked extended-release coated spheres
Journal Article · Mon Jan 01 00:00:00 EST 1990 · Pharmaceutical Research; (USA) · OSTI ID:6746788